Pseudomonas aeruginosa lipopolysaccharide inhibits Candida albicans hyphae formation and alters gene expression during biofilm development

Mol Oral Microbiol. 2013 Feb;28(1):54-69. doi: 10.1111/omi.12006. Epub 2012 Oct 12.

Abstract

Elucidation of bacterial and fungal interactions in multispecies biofilms will have major impacts on understanding the pathophysiology of infections. The objectives of this study were to (i) evaluate the effect of Pseudomonas aeruginosa lipopolysaccharide (LPS) on Candida albicans hyphal development and transcriptional regulation, (ii) investigate protein expression during biofilm formation, and (iii) propose likely molecular mechanisms for these interactions. The effect of LPS on C. albicans biofilms was assessed by XTT-reduction and growth curve assays, light microscopy, scanning electron microscopy (SEM), and confocal laser scanning microscopy (CLSM). Changes in candidal hypha-specific genes (HSGs) and transcription factor EFG1 expression were assessed by real-time polymerase chain reaction and two-dimensional gel electrophoresis, respectively. Proteome changes were examined by mass spectrometry. Both metabolic activities and growth rates of LPS-treated C. albicans biofilms were significantly lower (P < 0.05). There were higher proportions of budding yeasts in test biofilms compared with the controls. SEM and CLSM further confirmed these data. Significantly upregulated HSGs (at 48 h) and EFG1 (up to 48 h) were noted in the test biofilms (P < 0.05) but cAMP levels remained unaffected. Proteomic analysis showed suppression of candidal septicolysin-like protein, potential reductase-flavodoxin fragment, serine hydroxymethyltransferase, hypothetical proteins Cao19.10301(ATP7), CaO19.4716(GDH1), CaO19.11135(PGK1), CaO19.9877(HNT1) by P. aeruginosa LPS. Our data imply that bacterial LPS inhibit C. albicans biofilm formation and hyphal development. The P. aeruginosa LPS likely target glycolysis-associated mechanisms during candidal filamentation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphatases / drug effects
  • Biofilms / growth & development*
  • Candida albicans / drug effects*
  • Candida albicans / genetics
  • Candida albicans / physiology
  • Cyclic AMP / analysis
  • DNA-Binding Proteins / drug effects
  • Fungal Proteins / drug effects
  • Fungal Proteins / genetics
  • Gene Expression Regulation, Fungal / drug effects
  • Glycine Hydroxymethyltransferase / drug effects
  • Glycolysis / drug effects
  • Humans
  • Hydrolases / drug effects
  • Hyphae / drug effects*
  • Hyphae / genetics
  • Klebsiella pneumoniae / physiology
  • Lipopolysaccharides / pharmacology*
  • Membrane Glycoproteins / drug effects
  • Microbial Interactions
  • NADH, NADPH Oxidoreductases / drug effects
  • Phosphoglycerate Kinase / drug effects
  • Proteome / genetics
  • Pseudomonas aeruginosa / physiology*
  • Sugar Alcohol Dehydrogenases / drug effects
  • Transcription Factors / drug effects
  • Transcription, Genetic / drug effects

Substances

  • ALS3 protein, Candida albicans
  • DNA-Binding Proteins
  • ECE1 protein, Candida albicans
  • EFG1 protein, Candida albicans
  • Fungal Proteins
  • HWP1 protein, Candida albicans
  • HYR1 protein, Candida albicans
  • Lipopolysaccharides
  • Membrane Glycoproteins
  • Proteome
  • Transcription Factors
  • Cyclic AMP
  • Sugar Alcohol Dehydrogenases
  • galactitol 2-dehydrogenase
  • NADH, NADPH Oxidoreductases
  • flavodoxin NADPH oxidoreductase
  • Glycine Hydroxymethyltransferase
  • Phosphoglycerate Kinase
  • Hydrolases
  • Adenosine Triphosphatases